Clinical trial
Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing in Vitro Fertilization Embryo Transfer: A Prospective, Multicentre, Randomised, Double-blind, Placebo-controlled Trial
NCT04872660 is registered in ClinicalTrials.gov with Shandong University of Traditional Chinese Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing in Vitro Fertilization Embryo Transfer: A Prospective, Multicentre, Randomised, Double-blind, Placebo-controlled Trial
- Lead sponsor
- Shandong University of Traditional Chinese Medicine
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- June 15, 2021
- Completion date
- December 30, 2026
- Enrollment
- 800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.